Michelson Medical Research Foundation’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History

Michelson Medical Research Foundation’s Portfolio VWO Stock Details VWO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.62M	Hold	127,630	–	–	7.04%	5
2026 Q1	$6.9M	Hold	127,630	–	–	7%	5
2025 Q4	$6.86M	Hold	127,630	–	–	6.88%	6
2025 Q3	$6.91M	Hold	127,630	–	–	6.01%	7
2025 Q2	$6.31M	Hold	127,630	–	–	6.06%	6
2025 Q1	$5.78M	Hold	127,630	–	–	4.83%	8
2024 Q4	$5.62M	Sell	127,630 -109,000	-46%	-$5.07M	4.71%	9
2024 Q3	$11.3M	Hold	236,630	–	–	7.98%	2
2024 Q2	$10.4M	Hold	236,630	–	–	8.9%	2
2024 Q1	$9.88M	Hold	236,630	–	–	5.99%	5
2023 Q4	$9.73M	Hold	236,630	–	–	6.41%	4
2023 Q3	$9.28M	Hold	236,630	–	–	6.26%	5
2023 Q2	$9.63M	Hold	236,630	–	–	6.85%	6
2023 Q1	$9.56M	Hold	236,630	–	–	7.5%	5
2022 Q4	$9.22M	Buy	+236,630	New	+$9.02M	5.97%	7

Other funds holding VWO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Betterment LLC New York $59.1B AUM 18.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wealthfront Advisers Palo Alto, California $52B AUM 24.53% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

WIT LLC District Of Columbia, District of Columbia $6.26B AUM 22.48% 1-Year Est. Return

Michelson Medical Research Foundation's VWO Position: Q2 2026 in Review

Michelson Medical Research Foundation held its Vanguard FTSE Emerging Markets ETF (VWO) position steady in Q2 2026 at 127,630 shares worth $7.62M. The position accounts for 7.04% of the portfolio, ranked #5.

Michelson Medical Research Foundation first reported a position in VWO in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.3M in Q3 2024. 2,598 funds tracked by Wall St. Rank hold VWO as of Q2 2026.

Michelson Medical Research Foundation held 127,630 shares of Vanguard FTSE Emerging Markets ETF worth $7.62M as of Q2 2026.
Michelson Medical Research Foundation left its Vanguard FTSE Emerging Markets ETF share count unchanged in Q2 2026.
Vanguard FTSE Emerging Markets ETF made up 7.04% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #5 holding.
Michelson Medical Research Foundation first reported a position in Vanguard FTSE Emerging Markets ETF in Q4 2022 and has held it in 15 quarters since.
Michelson Medical Research Foundation's Vanguard FTSE Emerging Markets ETF position peaked at $11.3M in Q3 2024.
2,598 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.